MarginsXMarginsX
Home › Markets › ACUT

Accustem Sciences Inc. (ACUT)

ACUT is quoted over the counter, not listed on an exchange. Accustem Sciences Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.1180
-9.2% on the day
1-year return
-86.3%
Market cap
$1.9M
Nano cap. From the Nov 13, 2026 close × 16.1M shares (10-Q cover page, Aug 14, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerACUT, quoted over the counter
SEC CIK0001850767
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressNew York, NY
Incorporated inDE

Warning signs

Cash runway
0.1 months
$13K cash at June 30, 2026
Share count, 1 year
0.0%
2025-08-14 to 2026-08-14 · +41.6% over 3 years
Going-concern doubt
No
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-14
Cash and burn$13K cash; operating cash flow -$301K a quarter.Report 2026-06-30
Shares outstanding16,072,267 (2026-08-14); 16,072,267 a year earlier; 11,346,535 three years earlier.Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMercurius & Associates LLP, New Delhi, India; changed auditors 2 times in 24 months8-K 4.01 2025-01-02
Late filings, 12 months1 NT noticeNT 10-K 2026-03-31
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$98K-$253K-$249K$13K$63KNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$486K-$374K$12KNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
Not filed-$514K$22K$14K$23KNeeds four quarters10-K 2026-04-14
Q3 2025
2025-09-30
Not filed-$400K-$604K$14K$45KNeeds four quarters10-Q 2025-11-12
Q2 2025
2025-06-30
Not filed-$401K$22K$31K$66KNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$440K-$290K$36KNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2024
2024-12-31
Not filed-$372K$414$5K$25KNeeds four quarters10-K 2026-04-14
Q3 2024
2024-09-30
Not filed-$328K-$218K$37K$58KNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2023-01-19
Latest annual report10-K2026-04-14
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2025-11-26
Latest proxyDEFA14A2022-10-11

Source: SEC EDGAR submissions feed, 77 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier